{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:12:05Z","timestamp":1791317525612,"version":"4.3.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,11]]},"DOI":"10.1097\/qad.0b013e328304b38b","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T18:24:13Z","timestamp":1236277453000},"page":"1345-1354","source":"Crossref","is-referenced-by-count":121,"title":["Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994\u20132005"],"prefix":"10.1097","volume":"22","author":[{"given":"Kate","family":"Buchacz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose K","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen C","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/00002030-200409030-00013","article-title":"All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population","volume":"18","author":"Keiser","year":"2004","journal-title":"AIDS"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/jwh.2004.13.719","article-title":"Changing trends in clinical AIDS presentations and survival among HIV-1-infected women","volume":"13","author":"Charurat","year":"2004","journal-title":"J Womens Health (Larchmt)"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2005.00271.x","article-title":"Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003","volume":"6","author":"Krentz","year":"2005","journal-title":"HIV Med"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00002030-200208160-00012","article-title":"Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study","volume":"16","author":"Mocroft","year":"2002","journal-title":"AIDS"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/343862","article-title":"Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994\u20131998","volume":"186","author":"Louie","year":"2002","journal-title":"J Infect Dis"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.aids.0000216375.99560.a2","article-title":"Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion","volume":"20","author":"Smit","year":"2006","journal-title":"AIDS"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00126334-200309010-00015","article-title":"Recent trends in HIV-related inpatient admissions 1996\u20132000: a 7-state study","volume":"34","author":"Fleishman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00126334-200311010-00012","article-title":"Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy","volume":"34","author":"Floris-Moore","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00126334-200311010-00011","article-title":"Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women","volume":"34","author":"Gardner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1468-1293.2004.00250.x","article-title":"Changes in hospital admissions across Europe: 1995\u20132003. Results from the EuroSIDA study","volume":"5","author":"Mocroft","year":"2004","journal-title":"HIV Med"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/00002030-199907090-00016","article-title":"The changing pattern of admissions to a London hospital of patients with HIV: 1988\u20131997. Royal Free Centre for HIV Medicine","volume":"13","author":"Mocroft","year":"1999","journal-title":"AIDS"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/088922202317406646","article-title":"Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001","volume":"18","author":"Paul","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R16-12-20210130","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1086\/323978","article-title":"A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use","volume":"33","author":"Tashima","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"III40","DOI":"10.1097\/01.mlr.0000175621.65005.c6","article-title":"Hospital and outpatient health services utilization among HIV-infected adults in care 2000\u20132002","volume":"43","author":"Fleishman","year":"2005","journal-title":"Med Care"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00042560-200106010-00009","article-title":"Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy","volume":"27","author":"Gebo","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1542\/peds.2006-3268","article-title":"Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994\u20132003 nationwide inpatient sample","volume":"120","author":"Kourtis","year":"2007","journal-title":"Pediatrics"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/01.inf.0000220255.14636.b3","article-title":"Hospitalization trends among children and youths with perinatal human immunodeficiency virus infection, 1990\u20132002","volume":"25","author":"Bertolli","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"III3","DOI":"10.1097\/01.mlr.0000175632.83060.eb","article-title":"Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001","volume":"43","author":"Betz","year":"2005","journal-title":"Med Care"},{"key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.qai.0000171727.55553.78","article-title":"Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-12-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.aids.0000210610.52836.07","article-title":"Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality","volume":"20","author":"Wyatt","year":"2006","journal-title":"AIDS"},{"key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/01.aids.0000244201.11006.1c","article-title":"Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994\u20132003","volume":"20","author":"Kourtis","year":"2006","journal-title":"AIDS"},{"key":"R25-12-20210130","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/00002030-200208160-00007","article-title":"Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients","volume":"16","author":"Palella","year":"2002","journal-title":"AIDS"},{"key":"R26-12-20210130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/bmj.38369.669850.8F","article-title":"Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study","volume":"330","author":"Sabin","year":"2005","journal-title":"BMJ"},{"key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-12-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00000441-200407000-00007","article-title":"Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults","volume":"328","author":"Monier","year":"2004","journal-title":"Am J Med Sci"},{"key":"R29-12-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","article-title":"Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel","volume":"31","author":"Schambelan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-12-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R31-12-20210130","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"R32-12-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R33-12-20210130","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/429824","article-title":"Disorders of glucose metabolism among HIV-infected women","volume":"40","author":"Howard","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R34-12-20210130","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/428840","article-title":"Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment","volume":"40","author":"Gallant","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R35-12-20210130","first-page":"2411","article-title":"The cost-effectiveness of highly active antiretroviral therapy, Canada 1991\u20132001","volume":"18","author":"Beck","year":"2004","journal-title":"AIDS"},{"key":"R36-12-20210130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/QAI.0b013e3180517407","article-title":"The changing pattern of hospital care for persons living with HIV: 2000 through 2004","volume":"45","author":"Hellinger","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-12-20210130","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMsa042657","article-title":"Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy","volume":"352","author":"Sanders","year":"2005","journal-title":"N Engl J Med"},{"key":"R39-12-20210130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJM200402123500719","article-title":"Trends in rates of myocardial infarction among patients with HIV","volume":"350","author":"Holmberg","year":"2004","journal-title":"N Engl J Med"},{"key":"R41-12-20210130","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.281.24.2305","article-title":"Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study","volume":"281","author":"Shapiro","year":"1999","journal-title":"JAMA"},{"key":"R42-12-20210130","first-page":"659","article-title":"QuickStats: rate of hospitalizations for coronary atherosclerosis and acute myocaridal infarction (MI), by year - National Hospital Discharge Survey, United States, 1996-2005.","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200807110-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:06:26Z","timestamp":1618038386000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200807110-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328304b38b","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7,11]]}}}